400 related articles for article (PubMed ID: 19661531)
1. Clinical aspects and comorbidities of psoriasis.
Ayala F; Ayala F
J Rheumatol Suppl; 2009 Aug; 83():19-20. PubMed ID: 19661531
[TBL] [Abstract][Full Text] [Related]
2. Comorbidities in patients with psoriasis.
Gottlieb AB; Dann F
Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis comorbidities.
Gottlieb AB; Chao C; Dann F
J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognosis in patients with psoriasis.
Gulliver W
Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
[TBL] [Abstract][Full Text] [Related]
5. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
Sterry W; Strober BE; Menter A;
Br J Dermatol; 2007 Oct; 157(4):649-55. PubMed ID: 17627791
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis: cardiovascular risk factors and other disease comorbidities.
Wu Y; Mills D; Bala M
J Drugs Dermatol; 2008 Apr; 7(4):373-7. PubMed ID: 18459519
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
Gisondi P; Girolomoni G
Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
Sommer DM; Jenisch S; Suchan M; Christophers E; Weichenthal M
Arch Dermatol Res; 2006 Dec; 298(7):321-8. PubMed ID: 17021763
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis, the liver, and the gastrointestinal tract.
Gisondi P; Del Giglio M; Cozzi A; Girolomoni G
Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities in psoriasis.
Christophers E
Clin Dermatol; 2007; 25(6):529-34. PubMed ID: 18021889
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
[TBL] [Abstract][Full Text] [Related]
12. Metabolic comorbidities and psoriasis.
Gisondi P; Ferrazzi A; Girolomoni G
Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis as the marker of underlying systemic disease.
Kourosh AS; Miner A; Menter A
Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis and the metabolic syndrome.
Alsufyani MA; Golant AK; Lebwohl M
Dermatol Ther; 2010; 23(2):137-43. PubMed ID: 20415820
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
Müller A; Mulhall JP
Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.
Johnsson H; McInnes IB; Sattar N
Ann Rheum Dis; 2012 Apr; 71(4):480-3. PubMed ID: 22294632
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of comorbidities in psoriasis.
Naldi L; Mercuri SR
Dermatol Ther; 2010; 23(2):114-8. PubMed ID: 20415817
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis: comorbidities and associations.
Farley E; Menter A
G Ital Dermatol Venereol; 2011 Feb; 146(1):9-15. PubMed ID: 21317853
[TBL] [Abstract][Full Text] [Related]
19. The concept of psoriasis as a systemic inflammation: implications for disease management.
Reich K
J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis and the metabolic syndrome.
Gottlieb AB; Dann F; Menter A
J Drugs Dermatol; 2008 Jun; 7(6):563-72. PubMed ID: 18561588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
